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Abstract
Emerging evidence has identified sleep as a significant, but 
modifiable, risk factor for metabolic syndrome, diabetes, and 
obesity. Leptin, an adipocyte-derived peptide and a regula-
tor of food intake and energy expenditure, has been shown 
to be associated with a short sleep duration in the patho-
physiology of obesity and consequently type 2 diabetes. This 
review focuses on the current evidence indicating the effects 
of a short sleep duration on the regulation of leptin concen-
tration in association with obesity and diabetes mellitus. In 
summary, the evidence suggests that sleep deprivation, by 
affecting leptin regulation, may lead to obesity and conse-
quently development of type 2 diabetes through increased 
appetite and food intake. However, findings on the role of 
leptin in diabetes due to sleep deprivation are contradictory, 
and further studies with larger sample sizes are needed to 
confirm previous findings. © 2021 The Author(s)
Published by S. Karger AG, Basel
Introduction
Sleep is a biological and behavioral process that is fun-
damental for life and optimum health. Sleep is controlled 
by diurnal, homeostatic, and neurohormonal mecha-
nisms [1]. Existing research acknowledges that sleep is an 
essential modulator of cardiovascular function, glucose 
regulation, and hormonal release [2]. Sleep duration has 
also been shown to have a pivotal function in metabolic 
hormones and body weight and it has been linked to oth-
er biological mechanisms including inflammation, the 
autonomic nervous system, the coagulation system, en-
dothelial function, and metabolic regulation [3, 4]. Sleep 
quality varies in individuals according to factors such as 
age, gender, occupation, educational level, socioeconom-
ic status, race, family relationships, and pathological con-
ditions including insomnia, depression level, and sleep-
disordered breathing [5–7]. According to the US Nation-
al Sleep Foundation, adequate sleep duration requirements 
vary across lifespans and from person to person, with 7– 
9 h recommended for adults [8, 9]. In recent decades, the 
average sleep duration has decreased worldwide, and this 
is widely attributed to a modern lifestyle [10]. Based on 
National Sleep Foundation criteria, 75% of preadoles-
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cents and 45% of late adolescents experience sleep defi-
ciency [11].
Insufficient sleep is characterized by either a consider-
able reduction in sleep time during a certain period due 
to 24-h wakefulness or a reduction in sleep time less than 
the optimal level for individual needs. Sleep loss, related 
to a decreased total sleep time, can be a result of habitual 
behavior or the presence of a pathological condition in-
cluding addiction (medications or alcohol), anxiety, de-
pression, idiopathic, somatic and painful diseases, and 
subjective and psychophysiological insomnia [12].
The reports from recent epidemiological studies, me-
ta-analyses, and systematic reviews have indicated that 
sleep duration is significantly correlated with several ad-
verse health outcomes including diabetes mellitus, car-
diovascular diseases, coronary heart diseases and stroke, 
dyslipidemia, hypertension, metabolic disease, obesity, 
and mortality [1, 13–20]. Recent evidence proposes that 
that relationship between a short sleep duration, obesity, 
and diabetes risk may include at least 3 pathways, i.e., 
(1) an altered glucose metabolism, (2) up-regulation of 
hunger and appetite or dysregulation of appetite/satiety 
hormones, and (3) down-regulation of energy expendi-
ture [21].
Leptin, a metabolic hormone, has a pivotal function in 
balancing appetite and satiety via food intake regulation 
and energy homeostasis [22]. Leptin works in synergy 
with another metabolic hormone, i.e., ghrelin. Whereas 
leptin suppresses food intake and induces weight loss, 
ghrelin increasing hunger and food intake [22]. Leptin is 
the product of the ob gene, which has an impact on 
growth, metabolism, and reproduction [23, 24]. Leptin 
has several other biological roles in the body [24], includ-
ing functions in glucose homeostasis via suppression of 
insulin production in pancreatic β cells [25]. The regula-
tion of diurnal blood leptin is controlled by multiple fac-
tors such as gender, age, feeding, fasting, sleep, obesity, 
and endocrine disorders [26]. The concentration of se-
rum leptin is directly related to fat mass, where increased 
circulating leptin, termed leptin resistance, is related to 
obesity [27]. The proposed mechanisms involved in 
leptin resistance are comprised of a reduction in the num-
ber of leptin receptors, impairment of receptor function, 
a reduction in transport across the blood-brain barrier, 
and a circulating suppressor of leptin function [28]. Since 
a leptin deficit in lipodystrophy is accompanied by dys-
glycemia and insulin resistance, it is expected that glucose 
metabolism is affected by leptin resistance [28]. Defects 
or dysfunction in the leptin signaling pathway plays a role 
in the pathophysiology of obesity, diabetes mellitus, and 
cardiovascular disease, and downstream targets of leptin 
may have a therapeutic potential role in the management 
of diabetes [29, 30]. Furthermore, the adiponectin-leptin 
ratio has been found to be significantly correlated with 
the insulin resistance index in diabetes mellitus [31–33]. 
Leptin stimulates cytokine activation and immune-cell 
proliferation, which predisposes to inflammatory condi-
tions [34].
The evidence suggests a bidirectional relationship be-
tween sleep duration and leptin. Leptin has central neural 
specific effects beyond modulation of appetite alone [35]. 
Leptin concentrations display a circadian pattern, with its 
levels increasing during the first part of the night and then 
decreasing during the latter part of the night [36]. Fur-
thermore, leptin has a function in preserving deep sleep 
by antagonizing the orexin neuron function in the hypo-
thalamus [37]. The findings of animal studies presented 
that the orexin (hypocretin) system monitors sleep and 
wakefulness through interactions with the system that 
regulates energy homeostasis and facilitates adaptive in-
tensification of arousal in response to fasting. The orexin 
neuron actions are inhibited by leptin, blood glucose, and 
food intake [37–39]. An animal study in leptin-resistant 
(db/db) genetically obese and diabetic mice showed that 
impaired leptin signaling had deleterious impacts on the 
regulation of sleep duration [40]. This study proposed 
that leptin signaling plays an important role in coordina-
tion of sleep-wake states and metabolism. It appears that 
sleep-related changes in leptin level promote progression 
of metabolic and immune disorders. Leptin’s proinflam-
matory role [24, 41, 42] proposes that increased serum 
leptin levels in metabolic syndrome and obesity in a sleep 
deprivation status may be associated with low-grade sys-
temic inflammatory diseases, characterized by increased 
proinflammatory cytokine levels including interleukin-6 
and tumor necrosis factor (TNF)-α. Leptin regulates the 
brain appetite-regulating center with information about 
energy balance [43]. It has been believed that there is an 
interaction between leptin and insulin in peripheral tis-
sues [44, 45]. Leptin inhibits energy storage mechanisms, 
whereas insulin enhances leptin production [46]. Evi-
dence also indicates that leptin promotes insulin sensitiv-
ity through enhancement of fatty acid oxidation and de-
clined fat accumulation in non-adipose tissues. Leptin 
induces fatty acid oxidation in muscle via AMP-activated 
protein kinase (AMPK) [47]. Moreover, leptin has a sig-
nificant role in increasing the glucose uptake in skeletal 
muscle through a β-adrenergic mechanism and the hypo-





As one of the factors affecting leptin level regulation, 
the effect of sleep has been investigated in several experi-
mental studies. Sleep loss with an effect on appetite hor-
mone (leptin) and energy expenditure has been linked to 
an increased risk of obesity and diabetes. This review aims 
to provide an update on the influence of short sleep dura-
tion on leptin levels in association with obesity and dia-
betes mellitus.
Data Sources and Searches
PubMed, Google Scholar, and Science Direct were 
searched using the following terms: “leptin,” “sleep dura-
tion,” “sleep length,” “sleep period,” “sleep deprivation,” 
“sleep deficiency,” “sleep curtailment,” “sleep loss,” “short 
sleep duration,” “diabetes,” “weight gain,” and “obesity.” 
Original articles, reviews, and conference abstracts were 
included. Hand searching of reference lists was under-
taken to identify any additional eligible studies. Publica-
tion dates were limited to 2000–2020, and papers written 
in English were included.
Sleep Duration, Leptin, and Obesity
Obesity, the result of a modern lifestyle, has progres-
sively increased globally over the past century. The obe-
sity epidemic and its consequent metabolic dysfunctions 
have been paralleled by the reduction in sleep duration 
[48, 49]. It has been suggested by recent studies that sleep 
restriction adversely affects metabolic homeostasis, lead-
ing to increased hunger and appetite, and food intake, 
which consequently leads to insulin resistance [49, 50]. 
The appetite hormones ghrelin and leptin work in syn-
ergy to manage hunger and satiety. Ghrelin, a stomach-
derived peptide, increases appetite [51], while leptin 
sends a message to the brain and suppresses appetite [52]. 
Appetite hormones rise throughout the day to a peak at 
1: 00 p.m. and then decrease overnight to a nadir at 9: 00 
p.m., which might be the cause of low leptin levels in short 
sleepers [53]. It has been proposed that dysregulated 
leptin and ghrelin play a key role in the increased BMI in 
short sleepers [4]. In an early study by Spiegel et al. [54], 
2 days of sleep restriction (4 h) reduced leptin (18%) and 
elevated ghrelin levels (28%), indicative of an enhanced 
drive to eat (hunger, 24%; appetite, 23%) in young, healthy 
men. A study by Taheri et al. [4] showed that sleep dura-
tion below 7.7 h was associated with decreased leptin and 
increased ghrelin concentrations and consequently an in-
creased body mass. These researchers suggested that a 
leptin deficiency increases appetite and consequently 
may cause obesity. The Child and Adolescent Metabolic 
Syndrome cohort studies [55, 56] suggested that a short 
sleep duration (< 8 h/day), compared to a long (≥10 h/
day) sleep duration, affects the association of polygenic 
risk for obesity and the leptin pathway explains a key 
mechanism through a modification effect.
Thus far, there are conflicting results regarding leptin 
circulation in sleep curtailment, with its level being shown 
to be reduced [4, 57–59], unchanged [60–62], or elevated 
[63–67]. Chaput et al. [57], in their study in adults, re-
ported that a sleep duration of 5–6 h/day was associated 
with a reduction in leptin levels and an increased risk of 
obesity and overweight compared to 7–8 and 9–10 h/day. 
A study in postmenopausal women showed that a sleep 
duration of less than 6 h per night was associated with 
lower serum leptin level compared to a sleep duration of 
more than 8 h [59]. In a study in healthy men, Mullington 
et al. [58] reported a rapid reduction in leptin amplitude 
in that sleep deprivation period, which returned toward 
normal during the period of recovery sleep. Spiegel et al. 
[68] evaluated associations between leptin and sympa-
thovagal balance, cortisol, thyroid-stimulating hormone 
(thyrotropin or TSH), glucose, and insulin under differ-
ent bedtime conditions. They reported that sleep restric-
tion (4 h for 6 nights) was associated with a decrease in 
the mean and maximal levels and rhythm amplitude of 
leptin (–19, −26, and –20%, respectively) compared to an 
extended sleep time (12 h for 7 nights). The effects of a 
short sleep duration on leptin level have also been shown 
to be associated with an elevation of sympathovagal bal-
ance and alterations in the cortisol and TSH profiles [68]. 
The thyroid gland regulates thermogenesis (body tem-
perature) and appetite, and its dysfunction (hypothyroid-
ism or hyperthyroidism) results in alterations in body 
mass [69]. Furthermore, higher TSH levels are associated 
with obesity and a higher body mass [70–72]. The exact 
mechanism underlying the influence of TSH on obesity is 
still unclear, but increases in energy expenditure and hy-
perleptinemia have been proposed to be influenced in this 
relationship [69].
Although short-term sleep curtailment has been 
shown to be associated with activation of the stress sys-
tem, which leads to decreased leptin levels and increased 
hunger and appetite, acute loss of sleep in a less stressful 
environment has been shown to increase leptin levels in 
the body [66]. Therefore, it seems that a combination of 
sleep curtailment and activation of the stress system but 
not sleep loss itself may lead to decreased leptin levels and 
Sleep Curtailment and Leptin Circulation 217Obes Facts 2021;14:214–221
DOI: 10.1159/000514095
increased hunger [66]. Hayes et al. [65] have examined 
the level of leptin in association with a reduced sleep time 
among adults. They reported that a 1-h decrease in total 
sleep duration was associated with a 10% increase in 
leptin levels [65]. A study on salivary cortisol and leptin 
in young healthy women showed that a single night of 
restricted sleep (3 h) altered the diurnal pattern of cortisol 
rhythms (the level of morning cortisol was reduced, and 
afternoon/evening cortisol levels were elevated) and in-
creased morning leptin levels in subjects but it did not 
have an effect on hunger and craving scores [67]. Bosy-
Westphal et al. [73] found that consecutive nightly de-
creases in sleep duration significantly increased body 
weight, energy intake, glucose-induced thermogenesis, 
leptin/fat mass, free triiodothyronine, and free thyroxine 
[73]. Charles et al. [74] showed that both short (< 5 h) and 
long (> 8 h) sleep durations were associated with increased 
leptin levels related to obesity.
However, unaffected leptin levels have been reported 
in patients with a sleep deficiency [61]. In a study in men 
with and without insomnia, circulating levels of leptin 
and ghrelin were measured across the night. Serial mea-
surement of appetite hormones showed that ghrelin lev-
els were significantly lower in insomnia patients, whereas 
leptin did not differ between the groups. Furthermore, 
the findings of this study concluded that dysregulation in 
energy balance in patients with insomnia results in weight 
gain in this population [61]. A Circadian Locomotor Out-
put Cycles Kaput (CLOCK) gene study showed that a 
shorter sleep duration increased ghrelin levels with no ef-
fects on leptin values [60]. This study suggested that sleep 
reduction with alterations in ghrelin levels and changes 
in eating behaviors may affect weight and weight loss. 
Schmid et al. [62], in a study in healthy normal-weight 
men, reported that feelings of hunger and ghrelin levels 
were elevated after 1 night of total sleep deprivation, 
whereas morning serum leptin concentrations was unaf-
fected. A large multiethnic study also found no associa-
tion between sleep duration and leptin levels [75].
Sleep Duration, Leptin, and Diabetes
Sleep plays a critical role in glucose regulation, and 
sleep duration has been shown to have an inverse effect on 
endocrine function and carbohydrate metabolism [2, 76]. 
The link between sleep and glucose metabolism has been 
explored in several studies, where it has been proposed 
that both short [13, 77–80] and long sleep durations [81–
83] may increase the risk of developing obesity and con-
sequently diabetes mellitus. It was shown by a systematic 
and meta-analysis study that both short and long sleep 
durations in type 2 diabetes patients is significantly associ-
ated with an increase in hemoglobin A1c (HbA1c) levels, 
suggesting poorer glycemic control compared to that with 
a normal sleep duration, with the relationship being U-
shaped [84]. In another study both a short sleep duration 
(> 5.5 and 5.5–6.4 h) and a long sleep duration (7.5–8.4 h) 
were associated with an increase in the risk of metabolic 
syndrome, insulin resistance, and high-sensitivity C-reac-
tive protein in diabetic patients compared to those with 
6.5–7.4 h of sleep [85]. These findings also concluded that 
sleep duration has a U-shaped relationship with metabol-
ic syndrome and insulin resistance. A recent meta-analy-
sis confirmed that short sleep (> 6 compared to 7 h) may 
increase the risk of type 2 diabetes by approximately 30% 
[86]. It has been proposed that sleep deprivation impairs 
insulin sensitivity and pancreatic β-cell function and glu-
cose uptake by target cells, increasing insulin resistance 
and leading to type 2 diabetes [87–94]. Recent evidence 
suggests that the metabolic hormones leptin and ghrelin 
are involved in the relationship between sleep and dys-
regulation of insulin and glucose and increase the risk of 
diabetes [63, 68, 94–97]. Given the effects of sleep defi-
ciency on leptin levels and metabolism, a short sleep dura-
tion may mediate its effects on incident diabetes through 
weight gain [98, 99] (Fig. 1).
The reviews on the role of sleep restriction in the met-





















sleep duration impairs glucose tolerance and insulin sen-
sitivity, increases evening concentrations of cortisol and 
levels of ghrelin, decreases levels of leptin, and increases 
appetite and hunger [100, 101].
In contrast, a multiethnic study in a population at high 
risk for diabetes showed that a short sleep duration (≤5.5 
h) was associated with an increase in leptin levels [75]. A 
study in diabetic patients showed that an insufficient 
sleep duration increased the level of leptin and insulin re-
sistance compared to those with an appropriate sleep du-
ration [102]. A laboratory-based sleep study showed that 
sleep restriction (5 nights of 4 h in bed) impaired glucose 
homeostasis and increased fasting and insulin levels [63]. 
Sleep restriction was associated with an increase in after-
noon cortisol and leptin levels compatible with an in-
creased insulin resistance [63]. It has been reported that 
a 1-h reduction in sleep duration was associated with a 7% 
elevation in leptin levels [65]. Furthermore, a study in ro-
tating-shift-work women reported an inverse association 
between leptin levels and the risk of type 2 diabetes. How-
ever, there was no association between sleep duration, 
leptin levels, and diabetes [103].
Considering the role of leptin in regulation of energy 
consumption, a decrease in the production of leptin due 
to a lack of sleep may explain the contribution of adjust-
ment of this hormone to obesity, decreased insulin sensi-
tivity, and increased insulin resistance. It is noteworthy 
that elevation of serum leptin levels results in decreased 
leptin transport across the blood-brain barrier [104]. It 
has been indicated that when leptin reaches its threshold 
the blood-brain barrier limits the leptin transport from 
peripheral blood to the central nervous system, inhibiting 
its activity [105]. This condition may explain the eleva-
tion of leptin levels due to sleep restriction, where the ef-
fectiveness of it is attenuated. In this way, leptin resis-
tance, characterized by a decreased response to leptin due 
to a reduced receptor expression, is another possible 
mechanism that explains elevated leptin levels in the 
blood but decreased leptin effects [28]. Thus, in the case 
of elevated plasma leptin levels it does not consistently 
reflect increased leptin efficacy and function in glucose 
homeostasis [28].
In summary, recent evidence indicates that an insuf-
ficient sleep duration, with an effect on leptin metabo-
lism, may promote the development of type 2 diabetes 
through increased hunger/food intake and weight gain. 
Furthermore, leptin dysregulation contributes to de-
creased insulin secretion and sensitivity, increased insu-
lin resistance and inflammation, and consequently an in-
creased risk of diabetes mellitus. Several studies have in-
vestigated the role of a short sleep duration on leptin 
regulation; however, the findings regarding the role of 
leptin in diabetes as a consequence of sleep curtailment 
are conflicting and more studies with a larger sample size 
are required to confirm the previous findings.
Strengths and Limitations
We reviewed and discussed the probable mechanism 
underlying the effect of sleep duration on leptin regula-
tion as the potential physiological mechanism underlying 
obesity and type 2 diabetes. Potential limitations of this 
work include the conflation of sleep quality and sleep du-
ration where these were not always reported separately in 
the studies included in this review. Furthermore, this re-
view was conducted as a narrative review and as such a 
quality appraisal of the included papers was not under-
taken. Further work is required to compare the findings 
of both sleep quality and duration on leptin circulation 
related to obesity and diabetes.
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